137 related articles for article (PubMed ID: 11255674)
1. The use of chromatography to manufacture purer and safer plasma products.
Johnston A; Adcock W
Biotechnol Genet Eng Rev; 2000; 17():37-70. PubMed ID: 11255674
[No Abstract] [Full Text] [Related]
2. The current status of blood fractionation in the United States.
Sgouris JT
Vox Sang; 1972; 23(1):45-55. PubMed ID: 5081014
[No Abstract] [Full Text] [Related]
3. Blood products.
Med Lett Drugs Ther; 1979 Nov; 21(23):93-6. PubMed ID: 502967
[No Abstract] [Full Text] [Related]
4. The Sterways process: a new approach to inactivating viruses using gamma radiation.
Reid BD
Biologicals; 1998 Jun; 26(2):125-9. PubMed ID: 9811518
[TBL] [Abstract][Full Text] [Related]
5. Plasma fractionation in blood transfusion service.
Haskó F; Salamon M; Bartha K; Dobó P
Dev Biol Stand; 1987; 67():39-48. PubMed ID: 3111912
[TBL] [Abstract][Full Text] [Related]
6. New trends in plasma fractionation.
Steinbuch M
Haematologia (Budap); 1983; 16(1-4):39-51. PubMed ID: 6207083
[No Abstract] [Full Text] [Related]
7. Fractionation of plasma with polyethylene glycol.
Polson A; Ruiz-Bravo C
Vox Sang; 1972; 23(1):107-18. PubMed ID: 5081005
[No Abstract] [Full Text] [Related]
8. [Conditions for obtaining hemostatic preparations from donor plasma].
Kunakova NV; Diakonova SF; Rusanov VM; Rudnitskaia MZ
Gematol Transfuziol; 1989 Oct; 34(10):40-2. PubMed ID: 2515092
[No Abstract] [Full Text] [Related]
9. Plasma fractionation in the United States. A review for clinicians.
Ness PM; Pennington RM
JAMA; 1974 Oct; 230(2):247-50. PubMed ID: 4137885
[No Abstract] [Full Text] [Related]
10. New trends in plasma fractionation and plasma products.
Burnouf T
Vox Sang; 1994; 67 Suppl 3():251-3. PubMed ID: 7975504
[No Abstract] [Full Text] [Related]
11. [Modern methods for the manufacture of therapeutic coagulation factors].
Fuhge P; Gratz P; Geiger H
Behring Inst Mitt; 1986 Feb; (79):165-76. PubMed ID: 3087341
[TBL] [Abstract][Full Text] [Related]
12. Improved safety from plasma derivatives: purification and viral elimination characteristics of mononine.
Feldman F; Chandra S; Huang C
Acta Haematol; 1995; 94 Suppl 1():25-32; discussion 33-4. PubMed ID: 7571992
[TBL] [Abstract][Full Text] [Related]
13. [Isolation of blood coagulation factors (VII, VIII and IX)].
Dzegilenko NB
Gematol Transfuziol; 1990 May; 35(5):38-40. PubMed ID: 2118467
[No Abstract] [Full Text] [Related]
14. Plasma fractionation in England and Wales.
Vallet L
Vox Sang; 1972; 23(1):58-60. PubMed ID: 4628157
[No Abstract] [Full Text] [Related]
15. Human plasma fractionation and the impact of new technologies on the use and quality of plasma-derived products.
Brodniewicz-Proba T
Blood Rev; 1991 Dec; 5(4):245-57. PubMed ID: 1782484
[TBL] [Abstract][Full Text] [Related]
16. Affinity chromatography in the separation of human alpha 1-antitrypsin (alpha 1-AT) and antithrombin-III (AT-III).
D'Souza S; Ananthakrishnan R
Aust J Exp Biol Med Sci; 1979 Jun; 57(3):245-50. PubMed ID: 316999
[TBL] [Abstract][Full Text] [Related]
17. A novel core fractionation process of human plasma by expanded bed adsorption chromatography.
Lihme A; Hansen MB; Andersen IV; Burnouf T
Anal Biochem; 2010 Apr; 399(1):102-9. PubMed ID: 19995544
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous isolation and partial characterization of antithrombin III and alpha 1-proteinase inhibitor from horse plasma.
Kurdowska A; Koj A; Jaśkowska M
Acta Biochim Pol; 1982; 29(1-2):95-103. PubMed ID: 6983800
[No Abstract] [Full Text] [Related]
19. A therapeutic concentrate of coagulation factors II, IX and X from citrated, factor VIII-depleted plasma.
Middleton SM; Bennett IH; Smith JK
Vox Sang; 1973 May; 24(5):441-56. PubMed ID: 4691239
[No Abstract] [Full Text] [Related]
20. Chromatography of human plasma on aminohexyl Sepharose: separation of factor VIII/vWf and behaviour of factors II, VII, IX and X and antithrombin III.
Ruttyn Y; Brandin MP; Vijayalakshmi MA
J Chromatogr; 1989 Jul; 491(2):299-308. PubMed ID: 2509508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
